Hungary vs Jordan: Memorandum items, Financial derivatives (net marked to market)

Hungary
100.23 million
in 2025
Jordan
56.02 million
in 2025
Hungary rank
11th
Jordan rank
13th

Memorandum items, Financial derivatives (net marked to market) over time

  • Hungary
  • Jordan
-1.0B-500.0M0500.0M1.0B200020122025

How they compare

Hungary currently reports 100.23 million against 56.02 million in Jordan, a difference of 44.21 million.

That makes Hungary's figure about 1.8 times Jordan's.

The two have swapped places 9 times across 19 shared years of data; in 2007 it was Jordan ahead.

Hungary ranks 11th and Jordan ranks 13th of 66 countries.

Jordan has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Hungary Jordan Difference Ahead
2000s -30.87 million 0 30.87 million Jordan
2010s 98.18 million 116.93 million 18.76 million Jordan
2020s -79.44 million 665.56 million 745.00 million Jordan

Averages of every year both report within each decade.

Frequently asked questions

Which has higher memorandum items, financial derivatives (net marked to market), Hungary or Jordan?
Hungary, at 100.23 million against 56.02 million in Jordan as of 2025.
What is the difference in memorandum items, financial derivatives (net marked to market) between Hungary and Jordan?
44.21 million, with Hungary ahead.
How many years of comparable data are there for Hungary and Jordan?
19 years are reported by both, from 2007 to 2025.
How do Hungary and Jordan rank globally for memorandum items, financial derivatives (net marked to market)?
Hungary ranks 11th and Jordan ranks 13th of 66 countries.
Where does this data come from?
International Monetary Fund, published as Memorandum items, Financial derivatives (net marked to market), Assets (International Reserves and Foreign Currency Liquidity: Guidelines for a Data Template 2013 (IRFCL 2013), Monetary Authorities and Central Government excluding Social Security). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Hungary vs Jordan: Memorandum items, Financial derivatives (net marked to market). Statizoid, drawing on International Monetary Fund. Retrieved 14 September 2026, from https://financial-sector.statizoid.com/compare/memorandum-items-financial-derivatives-net-marked-to-market-assets-international-reserves/hungary/jordan/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under IMF Terms and Conditions (attribution required); please keep the attribution.

<a href="https://financial-sector.statizoid.com/compare/memorandum-items-financial-derivatives-net-marked-to-market-assets-international-reserves/hungary/jordan/">Hungary vs Jordan: Memorandum items, Financial derivatives (net marked to market)</a> — Statizoid

About this data

Indicator
Memorandum items, Financial derivatives (net marked to market), Assets (International Reserves and Foreign Currency Liquidity: Guidelines for a Data Template 2013 (IRFCL 2013), Monetary Authorities and Central Government excluding Social Security)
Source
International Monetary Fund
Licence
IMF Terms and Conditions (attribution required)
Coverage
68 places, 1,199 data points, 1999–2025
Last refreshed

The International Reserves and Foreign Currency Liquidity (IRFCL, or the “Reserves Data Template”) dataset includes data on the amount and composition of countries’ official reserve assets, other foreign currency assets held by monetary authorities and central governments, and short-term foreign currency obligations and related activities of monetary authorities and central governments that can lead to drains on official reserves and other foreign currency assets. This website re-disseminates IMF member countries' data on international reserves and foreign currency liquidity in a common template and in a common currency (the U.S. dollar). Historical data by country are also available. Please note that the re-dissemination of the template data by the Fund does not constitute endorsement of the quality of the data by the Fund.